期刊文献+

IDENTIFICATION OF SPECIFIC PEPTIDE LIGANDS FOR B-LYMPHOMA CELL AND ITS EFFECT ON TYROSINE PHOSPHORYLATION AND CELL APOPTOSIS

IDENTIFICATION OF SPECIFIC PEPTIDE LIGANDS FOR B-LYMPHOMA CELL AND ITS EFFECT ON TYROSINE PHOSPHORYLATION AND CELL APOPTOSIS
下载PDF
导出
摘要 Objective To search novel method for diagnosis and therapy of B-lymphoma, specific small mo-lecular peptide ligands against binding site of tumor cells were screened and its effects on signal transduction and cell apoptosis were tested. Methods Specific peptide ligands were screened by binding with site of human B lymphoma cell(OC1LY8)using peptide-bead libraries. The identified peptides were characterized with responsible cellsby rebinding test. The role of tyrosine phosphorylation of peptide ligand was tested by Western blot; and its apoptosispromoting role was observed by confocal fluorescent microscope. Results Specific peptide ligand was able to bind specifically to site on cell surface and enter into cytoplasm. Tetrameric peptide ligand was able to strongly trigger signal transduction resulting in tyrosine phosphorylation and cellular apoptosis in OC1LY8 cell line. Conclusion Screened peptide ligand can effectively bind with OC1LY8 cell, stimulate cellular tyro-sine phosphorylation and induce cellular apoptosis.
出处 《Chinese Medical Sciences Journal》 CAS CSCD 2004年第1期44-50,共7页 中国医学科学杂志(英文版)
关键词 B-cell lymphoma peptide ligand APOPTOSIS 特异性缩氨酸配合体 B-淋巴细胞 酪氨酸磷酸化 细胞凋亡 肿瘤治疗学 肿瘤细胞
  • 相关文献

参考文献15

  • 1[1]Lam KS, Salmon SE, Hersh EM, et al. A new type of synthetic peptide library for identifying ligand-binding activity. Nature 1991;354:82-4.
  • 2[2]Lam KS, Lou Q, Zhao ZG, et al. Idiotype specific peptides bind to the surface immunoglobulins of two murine B-cell lymphoma lines inducing signal transduction. Biomed Pept Proteins Nucleic Acids 1995;1:205-10.
  • 3[3]Lam KS. Treatment of B-cell lymphoma using peptides: a novel concept. West J Med 1993;158:475-9.
  • 4[4]McIntyre BS, Sylvester PW. Genistein and erbstatin inhibition of normal mammary epithelial cell proliferation is associated with EGF-receptor down-regnlation. Cell Prolif 1998;31:35-46.
  • 5[5]Steven IP, Renil M, Brian V, et al. Identification of peptide ligands for α4β1 integrin receptor as potential targeting agents for non-Hodgkin's lymphoma. Letters Peptide Sci 2002;8:171-8.
  • 6[6]Michigami T, Nomizu M, Yamada Y, et al. Growth and dissemination of a newly-established murine B-cell lymphoma cell line is inhibited by multimeric YIGSR peptide.Clin Exp Metastasis 1998;16:645-54.
  • 7[7]Siiman O, Burshteyn A. Cell surface receptor-antibody association constants and enumeration of receptor sites for monocloneal antibodies. Cytometry 2000;40:316-26.
  • 8[8]Yang C, Chang J, Gorospe M, et al. Protein tyrosine phosphatase regulation of endothelial cell apoptosis and differentiation. Cell Growth Differ 1996;7:161-71.
  • 9[9]Guo DQ, Wu LW, Dunbar JD, et al. Tumor necrosis factor employs a protein-tyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factor-induced endothelial cell proliferation. J Biol Chem 2000;275:11216-21.
  • 10[10]Yano S, Herbst RS, Shinohara H, et al. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Clin Cancer Res 2000;6:957-65.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部